Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer

Clinical trial NCT00230542 · COMPLETED

Trial details

NCT number: NCT00230542
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Peritoneal Cancer Fallopian Tube Cancer

Start date: 2005-09-01
Primary completion: 2007-07-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.